retatrutide trial results today Medscape | Retatrutide, Eli Lilly's first-in-class triple hormone receptor agonist, delivered meaningful weight loss at 80 weeks in all doses in the ๐จ BREAKING: Eli Lilly just
Pay in 4 interest-free payments of $5.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 30 - Sep 4








,aspect=ignore)









,aspect=ignore)








